IL177504A0 - Crystalline composition containing escitalopram oxalate - Google Patents

Crystalline composition containing escitalopram oxalate

Info

Publication number
IL177504A0
IL177504A0 IL177504A IL17750406A IL177504A0 IL 177504 A0 IL177504 A0 IL 177504A0 IL 177504 A IL177504 A IL 177504A IL 17750406 A IL17750406 A IL 17750406A IL 177504 A0 IL177504 A0 IL 177504A0
Authority
IL
Israel
Prior art keywords
composition containing
crystalline composition
escitalopram oxalate
containing escitalopram
oxalate
Prior art date
Application number
IL177504A
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2005/000115 external-priority patent/WO2005084643A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL177504A0 publication Critical patent/IL177504A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL177504A 2004-03-05 2006-08-15 Crystalline composition containing escitalopram oxalate IL177504A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200400382 2004-03-05
PCT/DK2005/000115 WO2005084643A1 (en) 2004-03-05 2005-02-21 Crystalline composition containing escitalopram oxalate

Publications (1)

Publication Number Publication Date
IL177504A0 true IL177504A0 (en) 2006-12-10

Family

ID=36607154

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177504A IL177504A0 (en) 2004-03-05 2006-08-15 Crystalline composition containing escitalopram oxalate

Country Status (9)

Country Link
KR (1) KR20060126587A (en)
CN (3) CN101492435A (en)
AR (1) AR047749A1 (en)
IL (1) IL177504A0 (en)
MY (1) MY142756A (en)
PE (1) PE20051162A1 (en)
SG (1) SG159504A1 (en)
TW (1) TW200605916A (en)
ZA (1) ZA200607382B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114763343A (en) * 2021-01-14 2022-07-19 浙江华海药业股份有限公司 Method for purifying citalopram or S-citalopram
CN113663356B (en) * 2021-08-23 2022-09-23 广西埃索凯新材料科技有限公司 Crystallization impurity removal monitoring system applied to manganese sulfate production

Also Published As

Publication number Publication date
TW200605916A (en) 2006-02-16
CN1925844A (en) 2007-03-07
ZA200607382B (en) 2008-05-28
CN101492435A (en) 2009-07-29
AR047749A1 (en) 2006-02-15
MY142756A (en) 2010-12-31
KR20060126587A (en) 2006-12-07
CN101492436A (en) 2009-07-29
SG159504A1 (en) 2010-03-30
PE20051162A1 (en) 2006-01-16

Similar Documents

Publication Publication Date Title
EP1718638A4 (en) Novel compounds
GB0409375D0 (en) Phytoactive composition
EP1726304A4 (en) Solifenacin-containing composition
GB0402140D0 (en) Novel compounds
GB0327340D0 (en) Ink-jet composition
ZA200701527B (en) Composition comprising statin
GB0425795D0 (en) Composition
GB0410038D0 (en) Composition
GB0416861D0 (en) Composition
EP1805132A4 (en) Novel compounds
EP1796793A4 (en) Novel compounds
GB0414803D0 (en) Composition
ZA200704974B (en) Composition
GB0415981D0 (en) Composition
GB0427403D0 (en) Novel compounds I
GB0417357D0 (en) Composition
GB0305790D0 (en) Novel Composition
GB0318824D0 (en) Novel composition
IL177504A0 (en) Crystalline composition containing escitalopram oxalate
GB0417388D0 (en) Composition
GB2418924B (en) Weathered-effect composition
GB0409598D0 (en) Composition
GB0415329D0 (en) Composition
GB0422975D0 (en) Composition
GB0415334D0 (en) Composition